Form 4: Acrivon Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Mary Miller, Chief Legal Officer of Acrivon Therapeutics, Inc., sold 294 shares of common stock on October 5, 2026 for $1.99 per share.
Summary
- Open-market sale: disposed of 294 Common Stock at $1.99 ($585) on October 5, 2026; holds 81,715 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $585 of stock on the open market.
Insider Transactions
Mary Miller — Officer (Chief Legal Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-05 | Open-market sale | Common Stock | 294 | $2 | $585 | 81,715 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-05 | Open-market sale (294 shares) |
Keywords
insider transaction, Form 4, ACRV, Acrivon Therapeutics, Inc., bearish, Mary Miller
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.